Ebola symptoms begin with a sudden fever, fatigue, muscle pain, and headache, typically appearing 2 to 21 days after exposure. The illness then progresses through distinct phases, with gastrointestinal symptoms hitting around days 4 to 5 and, in severe cases, bleeding and organ failure developing in the second week. How quickly symptoms worsen is one of the strongest indicators of outcome.
Early Symptoms: The First Few Days
The initial signs of Ebola look a lot like many other tropical infections, including malaria and typhoid. That overlap is one reason the disease can be difficult to identify early. The first symptoms are “dry” and nonspecific: fever, severe headache, muscle and joint pain, fatigue, and sore throat. These can start anywhere from 2 to 21 days after contact with the virus, though most people develop symptoms between 8 and 10 days.
At this stage, the virus is multiplying in the blood but may not yet be at detectable levels. It can take up to 3 days after symptoms appear before a blood test can confirm the infection.
Gastrointestinal Symptoms Take Over
After roughly four to five days of illness, the disease shifts to what clinicians call the “wet” phase. This includes severe abdominal pain, persistent vomiting, and watery diarrhea. The fluid loss from vomiting and diarrhea is intense and can quickly lead to dangerous dehydration, which is a major driver of complications. For many patients, managing this fluid loss is the single most important factor in survival.
Bleeding and Hemorrhage
Despite its reputation as a “hemorrhagic fever,” bleeding is not a universal symptom. About 40% of patients develop unexplained bleeding, and it tends to appear later in the disease course. When it does occur, it can show up in several ways: small red or purple spots under the skin, bruising, bleeding from the gums or nose, blood in vomit or stool, or oozing from any puncture wounds.
The bleeding happens because the virus triggers a chain reaction in the body’s clotting system. Infected immune cells release signals that activate clotting throughout the bloodstream, which paradoxically uses up clotting factors faster than the body can replace them. At the same time, the virus damages the lining of blood vessels, making them leaky. The combination of depleted clotting ability and fragile blood vessels is what leads to hemorrhage.
Organ Failure in Severe Cases
Patients with fatal disease tend to develop more severe symptoms earlier and typically die between days 6 and 16. The cause of death is usually a combination of multiple organ failure and septic shock, where blood pressure drops so low that organs stop receiving adequate blood flow.
The liver and kidneys are hit especially hard. Liver damage is reflected in dramatically elevated enzyme levels, sometimes more than ten times the normal range. Kidney function deteriorates as well. The pancreas can also become inflamed. These organs fail not just from direct viral infection but from the body’s own overwhelming immune response and the collapse of the circulatory system.
Neurological symptoms can also develop in severe cases, including confusion, irritability, aggression, and seizures. Brain swelling has been reported in some patients.
How Severity Varies by Strain
Not all Ebola viruses carry the same risk. A meta-analysis covering outbreaks from 1976 to 2022 found significant differences in fatality rates across the four known strains that infect humans. The Zaire strain, responsible for the largest outbreaks including the 2014 West Africa epidemic, is the deadliest at roughly 67%. The Sudan strain kills about 49% of those infected. The Bundibugyo strain has a fatality rate around 33%. The Taï Forest strain has caused only a single known human infection, which was not fatal.
What Survivors Face Afterward
Surviving Ebola does not mean a full return to health. A collection of lingering problems known as post-Ebola syndrome affects the majority of survivors, sometimes for months or years. Preliminary findings from survivor clinics indicate that about 68% experience neurological complications, 60% develop eye problems, and 53% have musculoskeletal issues.
Eye problems are among the most common and most concerning. At least 60% of survivors develop some form of ocular complication, ranging from inflammation inside the eye and light sensitivity to cataracts and permanent vision loss. Some of these problems appear within weeks of leaving the hospital, while others emerge months later.
Joint pain is another hallmark of post-Ebola syndrome, affecting roughly half of survivors and sometimes severe enough to be disabling. Fatigue can be crushing and persistent. Other reported symptoms include headaches, sleep disturbance, dizziness, skin rashes, difficulty swallowing, muscle weakness, hearing loss, and tinnitus. One survivor who initially seemed to recover well later experienced seizures attributed to scarring in the brain from the infection, requiring long-term medication. Another developed meningoencephalitis, an inflammation of the brain and its surrounding membranes, ten months after the initial illness.
These lingering effects highlight that Ebola’s impact extends well beyond the acute infection. For survivors, recovery is often measured in years rather than weeks.